Carmen Sucharov
Concepts (380)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 23 | 2025 | 692 | 5.700 |
Why?
| | Cardiomyopathy, Dilated | 19 | 2025 | 385 | 4.910 |
Why?
| | Myocytes, Cardiac | 18 | 2025 | 526 | 3.770 |
Why?
| | Myocardium | 12 | 2020 | 1002 | 2.180 |
Why?
| | Heart Failure | 16 | 2023 | 2236 | 1.840 |
Why?
| | Circulating MicroRNA | 3 | 2023 | 24 | 1.520 |
Why?
| | Gene Expression Regulation | 14 | 2018 | 2607 | 1.400 |
Why?
| | Connexin 43 | 3 | 2025 | 32 | 1.380 |
Why?
| | Ventricular Remodeling | 4 | 2021 | 266 | 1.220 |
Why?
| | Phosphodiesterase 3 Inhibitors | 3 | 2019 | 14 | 1.190 |
Why?
| | Receptors, Adrenergic, beta | 4 | 2016 | 127 | 1.180 |
Why?
| | Heart Ventricles | 13 | 2021 | 788 | 1.170 |
Why?
| | YY1 Transcription Factor | 6 | 2015 | 25 | 1.140 |
Why?
| | Phosphoric Diester Hydrolases | 3 | 2016 | 46 | 0.980 |
Why?
| | Histone Deacetylases | 5 | 2013 | 215 | 0.890 |
Why?
| | Phosphorylation | 9 | 2021 | 1759 | 0.850 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2017 | 121 | 0.840 |
Why?
| | Serum | 3 | 2019 | 59 | 0.840 |
Why?
| | Calcium-Binding Proteins | 4 | 2021 | 218 | 0.820 |
Why?
| | RNA-Binding Proteins | 2 | 2025 | 422 | 0.820 |
Why?
| | Transcriptome | 5 | 2021 | 971 | 0.800 |
Why?
| | RNA, Messenger | 11 | 2024 | 2833 | 0.780 |
Why?
| | Amniotic Fluid | 2 | 2024 | 96 | 0.740 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2023 | 142 | 0.730 |
Why?
| | Focal Adhesions | 1 | 2021 | 44 | 0.720 |
Why?
| | Rats | 16 | 2025 | 5647 | 0.710 |
Why?
| | Fetofetal Transfusion | 1 | 2021 | 26 | 0.700 |
Why?
| | Biomarkers | 8 | 2024 | 4149 | 0.670 |
Why?
| | Extracellular Matrix | 2 | 2021 | 528 | 0.660 |
Why?
| | Heart Defects, Congenital | 4 | 2021 | 842 | 0.650 |
Why?
| | Cardiomegaly | 5 | 2015 | 175 | 0.650 |
Why?
| | Down-Regulation | 7 | 2025 | 657 | 0.640 |
Why?
| | Adenylyl Cyclases | 2 | 2016 | 87 | 0.610 |
Why?
| | Receptors, Adrenergic, beta-1 | 2 | 2011 | 46 | 0.600 |
Why?
| | Phosphodiesterase Inhibitors | 2 | 2016 | 89 | 0.600 |
Why?
| | Signal Transduction | 11 | 2023 | 5079 | 0.590 |
Why?
| | Calcium | 2 | 2021 | 1199 | 0.570 |
Why?
| | Animals, Newborn | 8 | 2021 | 844 | 0.560 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 181 | 0.550 |
Why?
| | Protein Kinase C | 2 | 2011 | 261 | 0.550 |
Why?
| | Animals | 36 | 2025 | 36940 | 0.540 |
Why?
| | Cardiomyopathies | 1 | 2021 | 350 | 0.540 |
Why?
| | Child | 24 | 2025 | 21935 | 0.540 |
Why?
| | Ventricular Function, Left | 3 | 2018 | 534 | 0.530 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2017 | 323 | 0.510 |
Why?
| | Specimen Handling | 1 | 2018 | 183 | 0.500 |
Why?
| | Child, Preschool | 17 | 2025 | 11074 | 0.500 |
Why?
| | Plasma | 1 | 2018 | 212 | 0.500 |
Why?
| | Bleomycin | 5 | 2020 | 248 | 0.490 |
Why?
| | Ventricular Myosins | 3 | 2005 | 35 | 0.480 |
Why?
| | Exosomes | 1 | 2017 | 103 | 0.480 |
Why?
| | Real-Time Polymerase Chain Reaction | 5 | 2017 | 346 | 0.460 |
Why?
| | Humans | 56 | 2025 | 137585 | 0.460 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 860 | 0.460 |
Why?
| | Transcription Factors | 7 | 2016 | 1719 | 0.460 |
Why?
| | Cyclic AMP | 5 | 2019 | 234 | 0.460 |
Why?
| | Cells, Cultured | 14 | 2019 | 4193 | 0.450 |
Why?
| | Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 11 | 0.420 |
Why?
| | Gene Expression | 7 | 2017 | 1502 | 0.420 |
Why?
| | Polymorphism, Genetic | 2 | 2019 | 660 | 0.410 |
Why?
| | Female | 38 | 2025 | 73304 | 0.410 |
Why?
| | Superoxide Dismutase | 3 | 2020 | 346 | 0.400 |
Why?
| | Heart | 4 | 2021 | 655 | 0.400 |
Why?
| | Heart Transplantation | 4 | 2016 | 754 | 0.400 |
Why?
| | Myosin Heavy Chains | 4 | 2014 | 192 | 0.390 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2012 | 182 | 0.390 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 45 | 0.390 |
Why?
| | Case-Control Studies | 7 | 2025 | 3556 | 0.380 |
Why?
| | Male | 36 | 2025 | 67762 | 0.380 |
Why?
| | Adrenergic beta-1 Receptor Agonists | 1 | 2011 | 5 | 0.360 |
Why?
| | DNA-Binding Proteins | 5 | 2005 | 1502 | 0.360 |
Why?
| | Sex Characteristics | 3 | 2019 | 762 | 0.350 |
Why?
| | Mitochondria, Heart | 3 | 2024 | 102 | 0.350 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2011 | 45 | 0.350 |
Why?
| | Recovery of Function | 1 | 2015 | 653 | 0.340 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 136 | 0.330 |
Why?
| | Heart Diseases | 1 | 2013 | 346 | 0.320 |
Why?
| | RNA | 1 | 2016 | 921 | 0.320 |
Why?
| | Isoproterenol | 3 | 2018 | 113 | 0.300 |
Why?
| | Myocardial Infarction | 2 | 2018 | 1046 | 0.300 |
Why?
| | Gene Expression Profiling | 6 | 2021 | 1774 | 0.300 |
Why?
| | Milrinone | 2 | 2021 | 29 | 0.300 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2021 | 38 | 0.290 |
Why?
| | Adaptation, Physiological | 1 | 2012 | 553 | 0.290 |
Why?
| | Cardiac Output, Low | 2 | 2021 | 66 | 0.280 |
Why?
| | Cell Line | 3 | 2025 | 2847 | 0.280 |
Why?
| | 3' Untranslated Regions | 3 | 2025 | 145 | 0.280 |
Why?
| | Myocardial Contraction | 3 | 2019 | 341 | 0.270 |
Why?
| | Cardiolipins | 2 | 2020 | 85 | 0.260 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 263 | 0.260 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 67 | 0.250 |
Why?
| | Lung Injury | 2 | 2018 | 219 | 0.240 |
Why?
| | Rats, Sprague-Dawley | 3 | 2021 | 2486 | 0.230 |
Why?
| | Mice | 13 | 2024 | 17787 | 0.230 |
Why?
| | Antigens, Nuclear | 1 | 2004 | 18 | 0.230 |
Why?
| | Inflammation | 4 | 2020 | 2837 | 0.230 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5757 | 0.230 |
Why?
| | Infant | 9 | 2020 | 9465 | 0.230 |
Why?
| | Protein Kinases | 1 | 2006 | 319 | 0.220 |
Why?
| | Echocardiography | 2 | 2021 | 642 | 0.220 |
Why?
| | Disease Models, Animal | 7 | 2024 | 4295 | 0.210 |
Why?
| | Fetal Heart | 1 | 2024 | 55 | 0.210 |
Why?
| | Protein Isoforms | 1 | 2025 | 404 | 0.210 |
Why?
| | Age Factors | 6 | 2018 | 3295 | 0.200 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2014 | 188 | 0.200 |
Why?
| | Sarcomeres | 1 | 2023 | 96 | 0.200 |
Why?
| | Caloric Restriction | 1 | 2024 | 124 | 0.190 |
Why?
| | Glutathione | 1 | 2024 | 356 | 0.190 |
Why?
| | Adolescent | 8 | 2025 | 21513 | 0.190 |
Why?
| | Fetal Blood | 1 | 2024 | 327 | 0.190 |
Why?
| | Endopeptidase K | 1 | 2021 | 17 | 0.190 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2024 | 201 | 0.190 |
Why?
| | Receptor, EphA2 | 2 | 2018 | 19 | 0.180 |
Why?
| | Ribonucleases | 1 | 2021 | 55 | 0.180 |
Why?
| | Light Coagulation | 1 | 2021 | 8 | 0.180 |
Why?
| | Fetal Growth Retardation | 2 | 2024 | 565 | 0.180 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2013 | 767 | 0.180 |
Why?
| | Serum Response Factor | 1 | 2021 | 33 | 0.180 |
Why?
| | Fetoscopy | 1 | 2021 | 30 | 0.180 |
Why?
| | Mice, Transgenic | 3 | 2023 | 2167 | 0.180 |
Why?
| | Adult | 11 | 2024 | 37929 | 0.180 |
Why?
| | Phenotype | 5 | 2023 | 3196 | 0.170 |
Why?
| | Microscopy, Atomic Force | 1 | 2021 | 126 | 0.170 |
Why?
| | Mutation | 4 | 2023 | 3958 | 0.170 |
Why?
| | Cell Differentiation | 2 | 2025 | 1991 | 0.170 |
Why?
| | Drainage | 1 | 2021 | 173 | 0.170 |
Why?
| | Biological Products | 1 | 2023 | 216 | 0.160 |
Why?
| | Prospective Studies | 6 | 2024 | 7604 | 0.160 |
Why?
| | Cluster Analysis | 1 | 2021 | 499 | 0.160 |
Why?
| | Extracellular Fluid | 1 | 2019 | 31 | 0.160 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 91 | 0.160 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 10 | 0.160 |
Why?
| | Chromosome Fragility | 1 | 1999 | 2 | 0.150 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 285 | 0.150 |
Why?
| | Natriuretic Peptide, Brain | 2 | 2012 | 99 | 0.150 |
Why?
| | Apoptosis | 2 | 2019 | 2553 | 0.150 |
Why?
| | Ephrin-A2 | 1 | 2018 | 4 | 0.150 |
Why?
| | Troponin I | 1 | 2019 | 81 | 0.150 |
Why?
| | Trinucleotide Repeats | 1 | 1999 | 25 | 0.150 |
Why?
| | Fever | 1 | 2020 | 306 | 0.150 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2009 | 124 | 0.150 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 22 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2021 | 730 | 0.150 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 64 | 0.150 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 452 | 0.150 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2021 | 455 | 0.150 |
Why?
| | Prognosis | 3 | 2018 | 4030 | 0.140 |
Why?
| | Energy Metabolism | 1 | 2024 | 922 | 0.140 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2111 | 0.140 |
Why?
| | Myofibroblasts | 1 | 2019 | 127 | 0.140 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2018 | 107 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2189 | 0.140 |
Why?
| | Pregnancy | 4 | 2024 | 6763 | 0.140 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 596 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 976 | 0.140 |
Why?
| | Freezing | 1 | 2018 | 90 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 130 | 0.140 |
Why?
| | Blotting, Western | 3 | 2016 | 1226 | 0.130 |
Why?
| | Myocarditis | 1 | 2018 | 100 | 0.130 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2016 | 9 | 0.130 |
Why?
| | Pilot Projects | 1 | 2022 | 1710 | 0.130 |
Why?
| | Acute Lung Injury | 1 | 2020 | 287 | 0.130 |
Why?
| | Death, Sudden, Cardiac | 1 | 2018 | 185 | 0.130 |
Why?
| | Cell Size | 1 | 2017 | 91 | 0.130 |
Why?
| | Kidney | 2 | 2024 | 1468 | 0.130 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 80 | 0.130 |
Why?
| | Renin-Angiotensin System | 1 | 2017 | 85 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 391 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 815 | 0.130 |
Why?
| | Cardiotonic Agents | 2 | 2021 | 124 | 0.130 |
Why?
| | Critical Illness | 1 | 2022 | 811 | 0.130 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 3 | 2005 | 17 | 0.120 |
Why?
| | Transcription, Genetic | 5 | 2013 | 1457 | 0.120 |
Why?
| | Up-Regulation | 2 | 2018 | 843 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 285 | 0.120 |
Why?
| | Vascular Resistance | 1 | 2017 | 375 | 0.120 |
Why?
| | Protein Binding | 4 | 2013 | 2224 | 0.120 |
Why?
| | Sympathetic Nervous System | 1 | 2017 | 182 | 0.120 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 180 | 0.120 |
Why?
| | Receptors, Nicotinic | 1 | 2018 | 334 | 0.120 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 333 | 0.120 |
Why?
| | Stem Cell Transplantation | 1 | 2017 | 176 | 0.120 |
Why?
| | Liver | 1 | 2024 | 1943 | 0.120 |
Why?
| | Collagen Type III | 1 | 2015 | 16 | 0.120 |
Why?
| | Middle Aged | 10 | 2018 | 33479 | 0.120 |
Why?
| | DNA Primers | 3 | 2011 | 515 | 0.120 |
Why?
| | Transcriptional Activation | 2 | 2008 | 378 | 0.120 |
Why?
| | Hot Temperature | 1 | 2018 | 391 | 0.110 |
Why?
| | Electron Transport Complex IV | 1 | 1995 | 60 | 0.110 |
Why?
| | Lung | 4 | 2024 | 4060 | 0.110 |
Why?
| | Antibiotics, Antineoplastic | 3 | 2020 | 127 | 0.110 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1995 | 113 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 158 | 0.110 |
Why?
| | Microfilament Proteins | 1 | 2015 | 133 | 0.110 |
Why?
| | Heart Rate | 1 | 2018 | 822 | 0.110 |
Why?
| | Cohort Studies | 3 | 2022 | 5742 | 0.110 |
Why?
| | Hypertension, Pulmonary | 2 | 2017 | 1910 | 0.110 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 248 | 0.110 |
Why?
| | Stroke Volume | 1 | 2017 | 612 | 0.100 |
Why?
| | Biopsy | 1 | 2017 | 1129 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2828 | 0.100 |
Why?
| | ROC Curve | 1 | 2015 | 554 | 0.100 |
Why?
| | Analysis of Variance | 2 | 2016 | 1316 | 0.100 |
Why?
| | Nanoparticles | 1 | 2018 | 481 | 0.100 |
Why?
| | Promoter Regions, Genetic | 3 | 2004 | 1250 | 0.100 |
Why?
| | Peptides | 1 | 2018 | 985 | 0.100 |
Why?
| | Atrial Natriuretic Factor | 2 | 2016 | 57 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 852 | 0.090 |
Why?
| | Endothelium, Vascular | 1 | 2018 | 927 | 0.090 |
Why?
| | Young Adult | 2 | 2021 | 13209 | 0.090 |
Why?
| | Nuclear Proteins | 1 | 2016 | 712 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 1995 | 648 | 0.090 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2014 | 238 | 0.090 |
Why?
| | Fibrosis | 3 | 2019 | 552 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 305 | 0.080 |
Why?
| | Glycine | 1 | 2011 | 176 | 0.080 |
Why?
| | Heart-Assist Devices | 1 | 2016 | 552 | 0.080 |
Why?
| | Arginine | 1 | 2011 | 271 | 0.080 |
Why?
| | Genotype | 2 | 2020 | 1916 | 0.080 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 305 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2011 | 810 | 0.080 |
Why?
| | Cell Movement | 1 | 2013 | 967 | 0.080 |
Why?
| | PPAR alpha | 1 | 2008 | 58 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 283 | 0.070 |
Why?
| | Adenosine Monophosphate | 2 | 2021 | 66 | 0.070 |
Why?
| | Fibroblasts | 1 | 2013 | 996 | 0.070 |
Why?
| | Heart Function Tests | 1 | 2008 | 59 | 0.070 |
Why?
| | Time Factors | 4 | 2018 | 6828 | 0.070 |
Why?
| | Heat-Shock Proteins | 1 | 2008 | 143 | 0.070 |
Why?
| | Desmin | 1 | 2007 | 24 | 0.070 |
Why?
| | Genetic Markers | 2 | 2018 | 344 | 0.070 |
Why?
| | Computational Biology | 1 | 2011 | 644 | 0.070 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2006 | 6 | 0.060 |
Why?
| | Indole Alkaloids | 1 | 2006 | 7 | 0.060 |
Why?
| | Protein Phosphatase 2 | 1 | 2006 | 41 | 0.060 |
Why?
| | Carbazoles | 1 | 2006 | 83 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2019 | 513 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2013 | 2475 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 436 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 72 | 0.060 |
Why?
| | Cytoplasm | 1 | 2006 | 274 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 82 | 0.060 |
Why?
| | Adrenergic beta-Agonists | 1 | 2006 | 134 | 0.060 |
Why?
| | Aged | 6 | 2018 | 23961 | 0.060 |
Why?
| | Acute Coronary Syndrome | 1 | 2008 | 279 | 0.060 |
Why?
| | Ku Autoantigen | 1 | 2004 | 11 | 0.060 |
Why?
| | Calcium Channels, L-Type | 1 | 2006 | 118 | 0.060 |
Why?
| | Protein Transport | 1 | 2006 | 445 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2024 | 114 | 0.050 |
Why?
| | Citrate (si)-Synthase | 1 | 2024 | 60 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 103 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 861 | 0.050 |
Why?
| | Infant, Newborn | 3 | 2024 | 6079 | 0.050 |
Why?
| | Actins | 1 | 2006 | 416 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 33 | 0.050 |
Why?
| | Suppression, Genetic | 1 | 2003 | 25 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 193 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 201 | 0.050 |
Why?
| | Haplotypes | 2 | 2018 | 494 | 0.050 |
Why?
| | Mutagenesis | 1 | 2003 | 179 | 0.050 |
Why?
| | Glycolysis | 1 | 2024 | 321 | 0.050 |
Why?
| | Gene Deletion | 1 | 2003 | 391 | 0.050 |
Why?
| | Sheep | 1 | 2024 | 856 | 0.040 |
Why?
| | Ischemia | 1 | 2024 | 409 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 350 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3284 | 0.040 |
Why?
| | Linear Models | 2 | 2016 | 849 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2024 | 518 | 0.040 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 7 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 50 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2020 | 132 | 0.040 |
Why?
| | Transfection | 2 | 2007 | 945 | 0.040 |
Why?
| | Disease Progression | 1 | 2007 | 2757 | 0.040 |
Why?
| | X Chromosome | 1 | 1999 | 53 | 0.040 |
Why?
| | Minisatellite Repeats | 1 | 1999 | 42 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 678 | 0.040 |
Why?
| | Flecainide | 1 | 2018 | 7 | 0.040 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 1999 | 50 | 0.040 |
Why?
| | Brazil | 1 | 1999 | 167 | 0.040 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 200 | 0.040 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2018 | 37 | 0.040 |
Why?
| | Cell Membrane Permeability | 1 | 2018 | 78 | 0.040 |
Why?
| | Protective Factors | 1 | 2018 | 93 | 0.040 |
Why?
| | Guinea Pigs | 1 | 2018 | 158 | 0.040 |
Why?
| | Fragile X Syndrome | 1 | 1999 | 77 | 0.040 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 1 | 2018 | 73 | 0.040 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2018 | 114 | 0.040 |
Why?
| | DNA | 1 | 2004 | 1459 | 0.030 |
Why?
| | Genetics, Population | 1 | 1999 | 214 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2024 | 1317 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 320 | 0.030 |
Why?
| | Placenta | 1 | 2024 | 750 | 0.030 |
Why?
| | Inflammasomes | 1 | 2018 | 131 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 19 | 0.030 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 56 | 0.030 |
Why?
| | Sampling Studies | 1 | 2016 | 99 | 0.030 |
Why?
| | Galectin 3 | 1 | 2016 | 20 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2018 | 377 | 0.030 |
Why?
| | Cell Cycle | 1 | 2019 | 601 | 0.030 |
Why?
| | Transcription Elongation, Genetic | 1 | 2016 | 23 | 0.030 |
Why?
| | Transcription Initiation Site | 1 | 2016 | 43 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 351 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 372 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Acetylation | 1 | 2016 | 248 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2019 | 771 | 0.030 |
Why?
| | GA-Binding Protein Transcription Factor | 1 | 1995 | 5 | 0.030 |
Why?
| | Action Potentials | 1 | 2018 | 493 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 816 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1995 | 155 | 0.030 |
Why?
| | 3T3 Cells | 1 | 1995 | 163 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 1995 | 56 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1060 | 0.030 |
Why?
| | DNA, Complementary | 1 | 1995 | 272 | 0.030 |
Why?
| | Base Sequence | 2 | 1995 | 2181 | 0.030 |
Why?
| | Exons | 1 | 1995 | 355 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1995 | 375 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 17 | 0.030 |
Why?
| | Plasmids | 1 | 1995 | 363 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 75 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 523 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 1995 | 2900 | 0.030 |
Why?
| | Tissue Donors | 1 | 2016 | 425 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 64 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2013 | 115 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 121 | 0.030 |
Why?
| | HeLa Cells | 1 | 1995 | 636 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2016 | 324 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 198 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 191 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2016 | 965 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 617 | 0.020 |
Why?
| | Chromatin | 1 | 2016 | 519 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2013 | 455 | 0.020 |
Why?
| | Hydrogels | 1 | 2019 | 678 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 257 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1946 | 0.020 |
Why?
| | Binding Sites | 1 | 1995 | 1303 | 0.020 |
Why?
| | Exercise | 1 | 2003 | 2057 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 3015 | 0.020 |
Why?
| | Cattle | 1 | 2013 | 984 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1547 | 0.020 |
Why?
| | MADS Domain Proteins | 1 | 2009 | 5 | 0.020 |
Why?
| | Myogenic Regulatory Factors | 1 | 2009 | 57 | 0.020 |
Why?
| | MEF2 Transcription Factors | 1 | 2009 | 61 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2426 | 0.020 |
Why?
| | Registries | 2 | 2008 | 2035 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2008 | 45 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2008 | 42 | 0.020 |
Why?
| | Genes | 1 | 2008 | 230 | 0.020 |
Why?
| | Homozygote | 1 | 2008 | 203 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2008 | 297 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 171 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 293 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1086 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2007 | 28 | 0.020 |
Why?
| | Gene Frequency | 1 | 2008 | 521 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2007 | 96 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 410 | 0.020 |
Why?
| | Risk Assessment | 1 | 2016 | 3457 | 0.020 |
Why?
| | United States | 2 | 2018 | 14841 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 620 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2007 | 402 | 0.010 |
Why?
| | Risk Factors | 1 | 2018 | 10388 | 0.010 |
Why?
| | Genetic Testing | 1 | 2007 | 460 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2005 | 570 | 0.010 |
Why?
| | Mitochondria | 1 | 2008 | 948 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1353 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2734 | 0.010 |
Why?
| | Hospitalization | 1 | 2008 | 2199 | 0.010 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 1 | 1995 | 10 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1995 | 77 | 0.010 |
Why?
| | TATA Box | 1 | 1995 | 24 | 0.010 |
Why?
| | Deoxyribonuclease I | 1 | 1995 | 39 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1995 | 201 | 0.010 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1995 | 91 | 0.010 |
Why?
| | Genes, Reporter | 1 | 1995 | 269 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2008 | 10811 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1995 | 955 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 1995 | 362 | 0.010 |
Why?
|
|
Sucharov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|